James E Flynn Insider Trading $ONCR Oncorus, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Over the past year James E Flynn has been an insider in 10 companies. The total value of shares held by James E Flynn in these companies amounts to $12,414,862.

James E Flynn 10% Owner
Aclaris Therapeutics, Inc.
Director
Acutus Medical, Inc.
Director
AdaptHealth Corp.
10% Owner
Adverum Biotechnologies, Inc.
10% Owner
ALIMERA SCIENCES INC
Director, 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
Annexon, Inc.
10% Owner
ANTARES PHARMA, INC.
10% Owner
ARENA PHARMACEUTICALS INC
10% Owner
ARVINAS, INC.
10% Owner
aTYR PHARMA INC
10% Owner
Audentes Therapeutics, Inc.
10% Owner
Auspex Pharmaceuticals, Inc.
10% Owner
AVADEL PHARMACEUTICALS PLC
Director
AveXis, Inc.
10% Owner
Axogen, Inc.
10% Owner
Black Diamond Therapeutics, Inc.
10% Owner
Cabaletta Bio, Inc.
10% Owner
CAS MEDICAL SYSTEMS INC
10% Owner
CATALYST BIOSCIENCES, INC.
10% Owner
CONSTELLATION PHARMACEUTICALS INC
10% Owner
Cyclacel Pharmaceuticals, Inc.
10% Owner
CytomX Therapeutics, Inc.
Director
Deerfield Healthcare Technology Acquisitions Corp.
Director
DFP HEALTHCARE ACQUISITIONS CORP.
10% Owner
Dicerna Pharmaceuticals Inc
10% Owner
DUSA PHARMACEUTICALS INC
10% Owner
DYNAVAX TECHNOLOGIES CORP
10% Owner
Edgewise Therapeutics, Inc.
10% Owner
Editas Medicine, Inc.
10% Owner
eHealth, Inc.
10% Owner
EMAGEON INC
10% Owner
Fibrocell Science, Inc.
10% Owner
Frequency Therapeutics, Inc.
10% Owner
Generation Bio Co.
10% Owner
HI TECH PHARMACAL CO INC
10% Owner, Director
Homology Medicines, Inc.
10% Owner
INSPIRE PHARMACEUTICALS INC
10% Owner
Invuity, Inc.
10% Owner
ISTA PHARMACEUTICALS INC
10% Owner
Kiniksa Pharmaceuticals, Ltd.
10% Owner
Larimar Therapeutics, Inc.
10% Owner
Loxo Oncology, Inc.
10% Owner
LUMOS PHARMA, INC.
10% Owner
Mallinckrodt plc
10% Owner
MEDICINES CO /DE
10% Owner
Mirum Pharmaceuticals, Inc.
10% Owner
Neos Therapeutics, Inc.
10% Owner
NeurogesX Inc
10% Owner
NeuroMetrix, Inc.
10% Owner
NITROMED INC
10% Owner
Nkarta, Inc.
10% Owner
NxStage Medical, Inc.
Director
Oncorus, Inc.
10% Owner
PAR PHARMACEUTICAL COMPANIES, INC.
Director
Protara Therapeutics, Inc.
10% Owner
Recro Pharma, Inc.
10% Owner
REGENXBIO Inc.
10% Owner
Revolution Medicines, Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
RIGEL PHARMACEUTICALS INC
10% Owner
Schrodinger, Inc.
10% Owner
Shockwave Medical, Inc.
10% Owner
SteadyMed Ltd.
10% Owner
STREAMLINE HEALTH SOLUTIONS INC.
10% Owner
Syros Pharmaceuticals, Inc.
Director
Talon Therapeutics, Inc.
10% Owner
Terns Pharmaceuticals, Inc.
10% Owner
THIRD WAVE TECHNOLOGIES INC /WI
10% Owner
TriVascular Technologies, Inc.
10% Owner
Vanda Pharmaceuticals Inc.
10% Owner
VIA Pharmaceuticals, Inc.
10% Owner
Werewolf Therapeutics, Inc.
10% Owner
XENOPORT INC
10% Owner
XERIS PHARMACEUTICALS INC
$ 12414862 The total value of shares held by James E Flynn
Insider Rank

James E Flynn ranks 2,262 out of 350,000 insiders. Go to Insider Ranking to see more.

James E Flynn in Oncorus, Inc.

Trading Symbol: ONCR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: Director
Holdings: 620,480 shares
Latest Transaction: Oct 08 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 2,848,970
Shares Sold: 0
Share Difference: +2,848,970
Value Difference: -$15,000,000

Latest Insider Trading Transactions of James E Flynn in Oncorus, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000088
Value of Purchases ($)0000015,000,00015,000,000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.002,449,76100
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.007,499,99900
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorOption ExerciseC0.007,499,99900
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00109,6121,644,180312,282202.7 K to 312.3 K (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00445,1946,677,9101,268,344823.2 K to 1.3 M (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyP15.00445,1946,677,9101,268,344823.2 K to 1.3 M (+54.08 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700202,6700 to 202.7 K
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700823,150620.5 K to 823.2 K (+32.66 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00202,6700823,150620.5 K to 823.2 K (+32.66 %)
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00620,4800620,4800 to 620.5 K
Oct 08 2020ONCROncorus, Inc.Flynn James EDirectorBuyC0.00620,4800620,4800 to 620.5 K

Page:   1